H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $7.00 price target on Anixa Biosciences (NASDAQ: ANIX).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
